Another child casualty of a commercially-driven vaccination policy.
Dr. Lucija Tomjenovic, a post-doctoral biochemist at the University of British Columbia School of Medicine, presented an abstract at the International Conference on Pharmacovigilance and Clinical Trials held in Chicago (October, 2012). The abstract of a detailed scientific paper about to be published by the Open Access publication OMICS, describes the abnormal autoimmune response 14 days following vaccination with the quadrivalent human papillomavirus (HPV), which ultimately led to the death of a 15-year old girl.
In Spain, on October 9, 2012, Don Carlos Álvarez Dardet, Professor of Preventive Medicine and Public Health at the University of Alicante, and Dña Alicia Capilla Lanagrán, Vice President of the AAVP (the Association of those Affected by Papillomavirus Vaccines) held a press conference to explain the reasons behind requests by medical professionals urging a Moratorium on the use of HPV vaccines in Spain.
Indeed, in 2009, more than 10,000 health professionals and scientific associations signed a document entitled, “Reasons for a Moratorium on the use of HPV vaccines in Spain,” and submitted it to the Department of Health.
The AAVP posted their demand for removal of HPV vaccines and the creation of a compensation fund for vaccine injury victims. Their website: www.nogracias.eu
See Rough English translation of Spain’s demand.